Results 11 to 20 of about 117,739 (305)
Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France. [PDF]
PLoS ONE, 2014 PURPOSE: To estimate the number of venous thromboembolic events and related-premature mortality (including immediate in-hospital lethality) attributable to the use of combined oral contraceptives in women aged 15 to 49 years-old between 2000 and 2011 in ...
Aurore Tricotel +3 more
doaj +1 more source
Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study [PDF]
, 2005 Combined oral contraceptives,oral hormone replacement therapy and thrombophilias are recognised risk factors for venous thromboembolism in women.The objective of this study was to assess the risk of thromboembolism among women with thrombophilia who are ...
Brenkel, I. +10 more
core +1 more source
PLoS ONE, 2019 Previous research has suggested that women using oral contraceptives show weaker preferences for masculine men than do women not using oral contraceptives.
Urszula M Marcinkowska +4 more
doaj +1 more source
Use of depot medroxyprogesterone acetate and fracture risk [PDF]
, 2010 Depot medroxyprogesterone acetate (DMPA), which has a high rate of use among teenagers in Europe and the United States, has been associated with impaired bone mineral acquisition during adolescence and accelerated bone loss in later life.
Brauchli, Yolanda B. +4 more
core +1 more source
Oral contraceptive use and mortality after 36 years of follow-up in the Nurses\u27 Health Study: Prospective cohort study [PDF]
, 2014 Objective To determine whether use of oral contraceptives is associated with all cause and cause specific mortality. Design Prospective cohort study. Setting Nurses’ Health Study, data collected between 1976 and 2012. Population 121 701 participants were
Charlton, Brittany M +7 more
core +2 more sources
Research and Practice in Thrombosis and Haemostasis, 2020 Combined oral contraceptives and factor V Leiden mutation are multiplicative risk factors for venous thromboembolism. However, it remains unknown whether this multiplicative effect is reflected in thrombin generation assays.
Maxime G. Zermatten +3 more
doaj +1 more source
The progestogen content of combined oral contraceptives and venous thromboembolic risk [PDF]
, 2011 Peer ...
Hannaford, Philip C
core +1 more source
Clinics, 2013 OBJECTIVES: The aim of this study was to identify variations in nervous thresholds in different phases of the menstrual cycle in eumenorrheic women and users of oral contraceptives.
Mariana de Brito Barbosa +2 more
doaj +1 more source
Oral contraceptives combined with interferon β in multiple sclerosis [PDF]
, 2015 Objective: To test the effect of oral contraceptives (OCs) in combination with interferon b (IFN-b) on disease activity in patients with relapsing-remitting multiple sclerosis (RRMS).
Barletta, Valeria T. +10 more
core +3 more sources